These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Air line as a possible vector of quarantine cholera]. Fattorini M Minerva Med; 1973 Sep; 64(68):3550-6. PubMed ID: 4798211 [No Abstract] [Full Text] [Related]
3. Toxin receptors and their pathogenetic significance. Gyr K Acta Histochem Suppl; 1984; 29():95-102. PubMed ID: 6425929 [TBL] [Abstract][Full Text] [Related]
5. Toxigenic Vibrio cholerae serogroup O141-associated cholera-like diarrhea and bloodstream infection in the United States. Crump JA; Bopp CA; Greene KD; Kubota KA; Middendorf RL; Wells JG; Mintz ED J Infect Dis; 2003 Mar; 187(5):866-8. PubMed ID: 12599062 [TBL] [Abstract][Full Text] [Related]
6. Current developments with cholera vaccines: "Where do we go from here?". Finkelstein RA Prog Clin Biol Res; 1980; 47():133-42. PubMed ID: 7010372 [No Abstract] [Full Text] [Related]
7. Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea. Sánchez J; Holmgren J Curr Opin Immunol; 2005 Aug; 17(4):388-98. PubMed ID: 15963708 [TBL] [Abstract][Full Text] [Related]
8. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains. García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073 [No Abstract] [Full Text] [Related]
9. Cholera and the immune response. Holmgren J; Svennerholm AM Prog Allergy; 1983; 33():106-19. PubMed ID: 6338509 [No Abstract] [Full Text] [Related]
11. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru. Taylor DN; Cárdenas V; Sanchez JL; Bégué RE; Gilman R; Bautista C; Perez J; Puga R; Gaillour A; Meza R; Echeverria P; Sadoff J J Infect Dis; 2000 May; 181(5):1667-73. PubMed ID: 10823767 [TBL] [Abstract][Full Text] [Related]
12. [Genetic, molecular, and immunologic aspects of Vibrio cholerae infection]. Fica AE; Cabello FC Rev Med Chil; 1993 Mar; 121(3):312-20. PubMed ID: 8248646 [TBL] [Abstract][Full Text] [Related]
13. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate. Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477 [TBL] [Abstract][Full Text] [Related]
14. Current status of cholera and rise of novel mucosal vaccine. Yamamoto T Jpn J Infect Dis; 2000 Oct; 53(5):181-8. PubMed ID: 11135702 [TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis and clinical classification of cholera]. Loban KM; Pokrovskiĭ VI Klin Med (Mosk); 1973 Dec; 51(12):89-94. PubMed ID: 4779027 [No Abstract] [Full Text] [Related]
16. Cholera. Allen SH Skinmed; 2011; 9(4):215-7. PubMed ID: 21980704 [No Abstract] [Full Text] [Related]
17. Case records of the Massachusetts General Hospital. Case 19-2011. A 4-year-old Haitian boy with vomiting and diarrhea. Harris JB; Ivers LC; Ferraro MJ N Engl J Med; 2011 Jun; 364(25):2452-61. PubMed ID: 21696312 [No Abstract] [Full Text] [Related]
18. [Diarrhea caused by Vibrio cholerae and Salmonella muenchen]. López-Brea M; Baquero M; Enríquez A; Jiménez ML; Fadón A Rev Sanid Hig Publica (Madr); 1985; 59(7-8):835-8. PubMed ID: 3832366 [No Abstract] [Full Text] [Related]